Vnitr Lek 2005, 51(5):588-592

Systemic AL-amyloidosis with dominant clinical manifestation in digestive system

R. Kroupa1,*, M. Dastych1, M. Šenkyřík1, J. Lata1, P. Dítě1, S. Hotárková2, P. Hrobař3
1 Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. P. Dítě, DrSc.
2 Patologicko-anatomický ústav Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. J. Mačák, CSc.
3 Radiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. V. A. Válek, CSc.

Paper describes a case of atypical manifestation of systemic AL-amyloidosis associated with multiple myeloma in 69 year old women with long-term dyspeptic complaint assigned to chronic gastroduodenal ulcer disease. She repeatedly underwent surgery for duodenal stenosis. Weight loss and laboratory signs of severe malnutrition gradually proceeded until amyloid deposits were demonstrated in biopsy in repeated sampling from chronic gastric ulceration. The condition proceeded and the patient died for associated infectious complications. The autopsy demonstrated massive amyloid infiltration of myocardium, lungs, stomach, bowel and kidneys. Plasmocytosis corresponding to multiple myeloma was found in bone marrow. The case was closed as a primary systemic amyloidosis of light chain type (AL) in multiple myeloma with clinically dominant infliction of digestive tract and malabsorption. Amyloidosis must be considered in differential diagnosis of all chronic inflammatory changes and gastric and intestinal infiltration. For definite assessment of diagnosis a finding of amyloid fibrils in histological examination is required.

Keywords: primary AL-amyloidosis; malabsorption syndrome; multiple myeloma

Received: July 12, 2004; Accepted: October 9, 2004; Published: May 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kroupa R, Dastych M, Šenkyřík M, Lata J, Dítě P, Hotárková S, Hrobař P. Systemic AL-amyloidosis with dominant clinical manifestation in digestive system. Vnitr Lek. 2005;51(5):588-592.
Download citation

References

  1. Adam Z, Vorlíček J et al. Hematologie II. Přehled maligních hematologických nemocí. Praha: Grada Publishing 2001.
  2. Araoz PA, Batts KP, Mac Carty RL. Amyloidosis of the alimentary canal: radiologic-pathologic correlation of CT findings. Abdominal Imaging 2000; 25: 38-44. Go to original source... Go to PubMed...
  3. Brychta T, Pařenica J, Zatočil T et al. Restriktivní kardiomyopatie jako projev primární amyloidózy. Vnitř Lék 2004; 50: 66-71. Go to PubMed...
  4. Falk RH, Comenzo RL, Skinner M. The systemic amyloidozes, review article. N Eng J Med 1997; 337: 898-909. Go to original source... Go to PubMed...
  5. Hayman SR, Lacy MQ, Kyle RA et al. Primary systemic amyloidosis: a cause of malabsorption syndrome Am J Med 2001; 111: 535-540. Go to original source... Go to PubMed...
  6. Hurlstone DP. Iron-deficiency anemia comlicating AL amyloidosis with recurrent small bowel pseudoobstruction and hindgut sparing. J Gastroenterol Hepatol 2002; 17: 623-624. Go to original source... Go to PubMed...
  7. Husová L, Lata J, Hušek K et al. Primární amyloidóza jako neobvyklá příčina krvácení z trávicího ústrojí. Čes a Slov Gastroent 2000; 54: 112-116.
  8. Chang SS, Lu CL, Tsay SH et al. Amyloidosis-induced gastrointestinal bleeding in a patient with multiple myeloma. J Clin Gastroenterol 2001; 32: 161-163. Go to original source... Go to PubMed...
  9. Klener P et al. Vnitřní lékařství. Praha: Galén, 2. vydání, 2001.
  10. Kyle R, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Seminars in Hematology 1995; 32: 45-59.
  11. Peny MO, Debongnie JC, Haot J et al. Localized amyloid tumor in small bowel. Dig Dis Sci 2000; 45: 1850-1853. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.